Replies to post #97659 on NorthWest Biotherapeutics Inc (NWBO)

[Jimjames]

Big pharma execs would rather spend billions on a sure thing rather than tens/hundreds of millions on a gamble.

If a small time multi million dollar gamble went south, theyll easily be in the dog house or fired...versus buying into a up and coming bio who just had a positive p3 readout

[GoodGuyBill]

Turtle I disagree. If BMY wait until P3 is PR'd, They'd pay a major premium, perhaps 10-100 times what they would pay now. The prudent thing for them to do is do dd and determine the likelihood of FDA approval. Then based on that dd, try to get whatever deal they can now while the cost of failure is built into the stock. My opinion (all speculation at this point) is that BMY already knows DD, hence the trial. I would think they are willing to make a deal, LP isn't. She's going all the way!